spacer
home > ict > autumn 2009 > infrastructure and experience: the kiwi way
PUBLICATIONS
International Clinical Trials

Infrastructure and Experience: The Kiwi Way

 

New Zealand is an island country in the south-west Pacific comparable in size to the UK, the Philippines and the US state of Colorado. The capital is Wellington and the largest city and principal port is in Auckland. New Zealand boasts a multicultural population of around 4.2 million people. Seventy per cent of the population live in towns or cities, which ensures good access to clinical trial centres for most of the country’s population. New Zealand’s small size and location has helped mould the country into becoming practical and innovative. The need to be globally focused in whatever New Zealand does is paramount, and this is demonstrated by collaborations with leading research institutes and companies, and a number of trade agreements.

CENTRAL ETHICS REVIEW

Within New Zealand, the health and disability ethics committees provide protection for research participants in the health and disability sector (1). Ethics committee reviews are primarily designed to:

  • Prevent studies that pose an unacceptable risk of harm to participants from going ahead
  • Ensure that all participants in research are aware of what their participation will involve and have given informed consent

New Zealand has a central review system; ethical review of health and disability research in New Zealand is carried out by seven health and disability ethics committees.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Christine Weston is currently Director of Infinity Consulting Ltd, an independent clinical research consultant. She has 14 years’ experience in the New Zealand clinical trial industry, including nine years as Head of Clinical Research for a multinational pharma company.

Shaun Holt is the Director and founder of Clinicanz, New Zealand’s only site management organisation. Previously, he was the founder of P3 Research and Research Review. Shaun holds Pharmacy and Medicine degrees, has been the Principal Investigator in over 50 clinical trials, and has over 50 publications in medical literature.

spacer
Christine Weston
spacer
spacer
spacer
Shaun Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection • Established platform technology to reliably scale target molecules • Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement